Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Journey Medical (DERM) EBT (2020 - 2025)

Historic EBT for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.

  • Journey Medical's EBT rose 313.81% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year increase of 5309.17%. This contributed to the annual value of -$14.6 million for FY2024, which is 30228.52% down from last year.
  • According to the latest figures from Q3 2025, Journey Medical's EBT is -$2.3 million, which was up 313.81% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, Journey Medical's EBT registered a high of $16.9 million during Q3 2023, and its lowest value of -$15.3 million during Q2 2021.
  • Moreover, its 5-year median value for EBT was -$4.1 million (2025), whereas its average is -$5.3 million.
  • Its EBT has fluctuated over the past 5 years, first plummeted by 2706346.15% in 2021, then surged by 26766.63% in 2023.
  • Journey Medical's EBT (Quarter) stood at -$13.4 million in 2021, then grew by 20.77% to -$10.6 million in 2022, then skyrocketed by 81.02% to -$2.0 million in 2023, then skyrocketed by 178.43% to $1.6 million in 2024, then tumbled by 246.33% to -$2.3 million in 2025.
  • Its EBT was -$2.3 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$4.1 million in Q1 2025.